Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001857478 | SCV002177786 | uncertain significance | Hypertrophic cardiomyopathy | 2022-07-03 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 1541 of the MYH7 protein (p.Gln1541Pro). This missense change has been observed in individual(s) with autosomal dominant distal myopathy (PMID: 24664454). ClinVar contains an entry for this variant (Variation ID: 143210). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV003236783 | SCV003935423 | uncertain significance | not provided | 2022-12-19 | criteria provided, single submitter | clinical testing | Reported in the heterozygous state in a family with distal myopathy (Lamont et al., 2014); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 24664454) |
Neurogenetics Laboratory, |
RCV000132749 | SCV000119900 | pathogenic | MYH7-related skeletal myopathy | 2013-01-01 | no assertion criteria provided | clinical testing |